Cutting edge: Both activating and inhibitory Fc receptors expressed on mast cells regulate experimental allergic encephalomyelitis disease severity

Journal of Immunology

Volumn 170, Issue 4, 2003, Pages 1630-1634

  Robbie Ryan, Michaela ^a   Tanzola, Melinda B ^a   Secor, Virginia H ^a   Brown, Melissa A ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FC RECEPTOR; MYELIN OLIGODENDROCYTE GLYCOPROTEIN;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE MARROW; CELL ACTIVATION; CONTROLLED STUDY; DISEASE COURSE; DISEASE SEVERITY; FEMALE; IMMUNIZATION; MAST CELL; MOUSE; MULTIPLE SCLEROSIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RELAPSE; REMISSION; SIGNAL TRANSDUCTION; SYMPTOMATOLOGY;

EID: 0037442191     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.170.4.1630     Document Type: Article

References (21)

1. Steinman, L. 1996. Multiple sclerosis: a coordinated immunological attack against myelin in the central nervous system. Cell 85:299.
2. Wedemeyer, J., M. Tsai, and S. Galli. 2000. Roles of mast cells and basophils in innate and acquired immunity. Curr. Opin. Immunol. 12:624.
3. Brown, M., M. Tanzola, and M. Robbie-Ryan. 2002. Mechanisms underlying mast cell influence on EAE disease course. Mol. Immunol. 38:1373.
4. Pedotti, R., D. Mitchell, J. Wedemeyer, M. Karpuj, D. Chabas, E. M. Hattab, M. Tsai, S. J. Galli, and L. Steinman. 2001. An unexpected version of horror autotoxicus: anaphylactic shock to a self-peptide. Nat. Immunol. 2:216.
5. Ansel, J., J. R. Brown, D. G. Payan, and M. A. Brown. 1993. Substance P selectively activates TNF-α gene expression in murine mast cells. J. Immunol. 150:4478.
6. Lock, C., G. Hermans, R. Pedotti, A. Brendolan, E. Schadt, H. Garren, A. Langer-Gould, S. Strober, B. Cannella, J. Allard, et al. 2002. Gene-microarray analysis of multiple sclerosis lesions yields new targets validated in autoimmune encephalomyelitis. Nat. Med. 8:500.
7. Secor, V. H., W. E. Secor, C. A. Gutekunst, and M. A. Brown. 2000. Mast cells are essential for early onset and disease severity in a murine model of multiple sclerosis, J. Exp. Med. 191:813.
8. Supajatura, V., H. Ushio, A. Wada, K. Yahiro, K. Okumura, H. Ogawa, T. Hirayama, and C. Ra. 2002. Cutting edge: VacA, a vacuolating cytotoxin of Helicobacter pylori, directly activates mast cells for migration and production of proinflammatory cytokines. J. Immunol. 168:2603.
9. Supajatura, V., H. Ushio, A. Nakao, S. Akira, K. Okumura, C. Ra, and H. Ogawa. 2002. Differential responses of mast cell Toll-like receptors 2 and 4 in allergy and innate immunity. J. Clin. Invest. 109:1351.
10. Okayama, Y., D. Hagaman, M. Woolhiser, and D. Metcalfe. 2001. Further characterization of FcγRII and FcγRIII expression by cultured human mast cells. Int. Arch. Allergy Immunol. 124:155.
11. Ott, V., and J. Cambier. 2000. Activating and inhibitory signaling in mast cells: new opportunities for therapeutic intervention. J. Allergy Clin. Immunol. 106:429.
12. Miyajima, I., D. Dombrowicz, T. Martin, J. Raverch, J.-P. Kinet, and S. Galli. 1997. Systemic anaphylaxis in the mouse can be mediated largely through IgG and FcγRIII. J. Clin. Invest. 99:901.
13. Takai, T. 2002. Roles of Fc receptors in autoimmunity. Nat. Rev. Immunol. 2:580.
14. Abdul-Majid, K.-B., A. Stefferl, C. Bourquin, H. Lassmann, C. Linington, T. Olsson, S. Kleinaus, and R. A. Harris. 2002. Fc receptors are critical for autoimmune inflammatory damage to the central nervous system in experimental autoimmune encephalomyelitis. Scand. J. Immunol. 55:70.
15. Cross, A., J. Trotter, and J.-A. Lyons, 2001. B cells and antibodies in CNS demyelinating disease. J. Neuroimmunol. 112:1.
16. Raine, C. S., B. Cannella, S. L. Hauser, and C. P. Genain. 1999. Demyelination in primate autoimmune encephalomyelitis and acute multiple sclerosis lesions: a case for antigen specific antibody mediation. Ann. Neurol. 46:144.
17. Genain, C. P., B. Cannella, S. L. Hauser, and C. S. Raine. 1999. Identification of autoantibodies associated with myelin damage in multiple sclerosis. Nat. Med. 5:170.
18. Bernard, C. C., T. G. Johns, A. Slavin, M. Ichikawa, C. Ewing, J. Liu, and J. Bettadapura. 1997. Myelin oligodendrocyte glycoprotein: a novel candidate autoantigen in multiple sclerosis. J. Mol. Med. 75:77.
19. v mice: evidence that cultured mast cells can give rise to both connective tissue type and mucosal mast cells. J. Exp. Med. 162:1025.
20. Myhr, K.-M., G. Raknes, H. Nyland, and C. Vedeler. 1999. Immunoglobulin G Fc-receptor (FcγR) IIA and IIIB polymorphisms related to disability in MS. Neurology 52:1771.
21. Regner, M., and P. H. Lambert. 2001. Autoimmunity through infection or immunization? Nat. Immunol. 2:185.